MedTrace Logo

Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

NCT05741008 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-04-27

No results posted yet for this study

Summary

To determine whether subtractive radiotherapy can significantly reduce the acute side effects of radiotherapy and improve the quality of life of patients on the basis of ensuring the existing curative effect.

Conditions

  • Toxicity Due to Radiotherapy
  • Nasopharyngeal Carcinoma

Interventions

RADIATION

Target range

Compared with conventional radiotherapy, the target dose is unchanged and the CTV2 volume is reduced.

Sponsors & Collaborators

  • First Affiliated Hospital of Kunming Medical University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-03-25
Completion
2025-03-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05741008 on ClinicalTrials.gov